Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure

Abstract Background Recent studies indicated that sodium glucose cotransporter (SGLT)2 inhibition increases levels of ketone bodies in the blood in patients with type 1 and 2 diabetes. Other studies suggested that in patients with chronic heart failure (CHF), increased myocardial oxygen demand can b...

Full description

Saved in:
Bibliographic Details
Main Authors: R. Pietschner, J. Kolwelter, A. Bosch, K. Striepe, S. Jung, D. Kannenkeril, C. Ott, M. Schiffer, S. Achenbach, R. E. Schmieder
Format: article
Language:EN
Published: BMC 2021
Subjects:
Online Access:https://doaj.org/article/b7b30358f28b414ca7ef3d20f55fd8c2
Tags: Add Tag
No Tags, Be the first to tag this record!